Floatz logo

Nanocis

Endometrioid Carcinoma

Centre Oscar LambretPhase 3Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Endometrioid Carcinoma cohort.

Asset / SponsorPhaseRating
Indocyanine Green
Centre Oscar Lambret
Phase 3B
PATENT BLUE VIOLET
Centre Oscar Lambret
Phase 3B
C.I. ACID BLUE 3
Centre Oscar Lambret
Phase 3B
Nanocoll
Centre Oscar Lambret
Phase 3B
Pembrolizumab
Peking University People's Hospital
N/AD
Medroxyprogesterone acetate
Peking University People's Hospital
N/AD
MEGESTROL ACETATE IMPURITY B
Peking University People's Hospital
N/AD

Same molecule, other indications

Nanocis is also rated in:

Non Endometrioid CarcinomaDormant
B
Indicative ·
60 / 100
View asset →
Breast CancerDormant
CCC
Indicative ·
48 / 100
View asset →
Failed Back Surgery SyndromeDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →